MedPath

A prospective observational study on mechanism of pulmonary fibrosis and a signature molecule based on pathology of progressive fibrosing interstitial lung diseases

Not Applicable
Recruiting
Conditions
Interstitial lung diseases
Registration Number
JPRN-UMIN000041871
Lead Sponsor
Kochi Medical School, Kochi University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Cases not possible to cooperate with ex aminations such as pulmonary function t ests. 2. Cases with active respiratory infectio n. 3. Cases in which informed consent was obt ained for this study. 4. Cases judged by the attending physicia n to be an ineligible.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The differences in subsets and activation of T cells, B cells, macrophages, and granulocytes in bronchoalveolar lavage fluid and peripheral blood is compared with or without pulmonary fibrosis. Investigate the relationship between such deviation on cellular subsets and/or activation with later prognosis of ILD patients at 12 months.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath